T Stock Chart Sat, Feb 1st, 2014

New Post Public Reply Private Reply Replies (0) Message Board
chartguy89
T Stock Chart and Technical Analysis - Sat, Feb 1st, 2014 $T

Period  Moving Average  Price Change  Percent Change  Average Volume
5 Day  33.44  -0.10  -0.30%  41,082,219
20 Day  33.78  -1.63  -4.66%  30,154,484
50 Day  34.38  -2.28  -6.40%  23,518,264
100 Day  34.54  -0.31  -0.92%  24,316,053
200 Day  35.13  -4.46  -11.81%  23,668,420
Year to Date  33.84  -1.84  -5.23%  29,682,037

Period  Raw Stochastic  Stochastic %K  Stochastic %D  Average True Range
9 Day 57.46% 57.75% 52.68% 0.65
14 Day 57.46% 57.75% 48.88% 0.59
20 Day 41.59% 40.69% 34.46% 0.55
50 Day 33.42% 33.59% 28.20% 0.50
100 Day 27.35% 27.49% 23.21% 0.49

Period  Relative Strength  Percent R  Historic Volatility  MACD Oscillator
9 Day 39.11% 42.54% 12.26% -0.15
14 Day 39.98% 42.54% 12.28% -0.21
20 Day 41.18% 58.41% 14.25% -0.46
50 Day 44.97% 66.58% 12.47% -1.05
100 Day 47.05% 72.65% 14.53% -1.22

T Stock Chart and Technical Analysis - Sat, Feb 1st, 2014
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing

Updated Category News Views 308

Ameripath USA's New Partnership for Recovery Housing Ameripath USA has formed a strategic partnership with Recovery Resolutions LLC to significantly improve access to high-quality Addiction Recovery Homes throughout the country. This collaboration merges Ameripath's extensive real estate expertise with Recovery Resolutions' impressive success model, boasting a 95% success...

Continue Reading
Finzly’s ISO 20022 Migration Readiness Sets Industry Standards

Updated Category News Views 311

Finzly’s Innovations in ISO 20022 Payment Standards Finzly is at the forefront of transforming how financial institutions manage payments through its state-of-the-art platform designed for modern banking needs. As the shift to SWIFT MX ISO 20022 continues, Finzly's clientele is emerging as early adopters, demonstrating a commitment to embracing new technologies that...

Continue Reading
Innovative Drug Delivery Solutions for Parkinson's Disease

Updated Category News Views 251

Serina Therapeutics' Approach to Parkinson's Disease Serina Therapeutics is at the forefront of developing new treatments for complex neurological disorders, particularly Parkinson’s disease. This progressive neurological disorder significantly impacts motor functions and quality of life for those affected. With innovative solutions on the horizon, Serina is prepared to...

Continue Reading
Waters Corporation Leader to Speak at HealthCONx Conference

Updated Category News Views 124

Waters Corporation to Participate in HealthCONx Conference Waters Corporation (NYSE: WAT), located in Milford, Massachusetts, is pleased to announce its participation in the upcoming HealthCONx Conference. Udit Batra, the President and Chief Executive Officer of Waters, will engage in an insightful fireside chat set for Wednesday, December 4th, 2024, at 10:00 AM Eastern...

Continue Reading
mRNA Synthesis and Manufacturing Market Expected to Grow Steadily

Updated Category News Views 33

Growing Insights into the mRNA Synthesis and Manufacturing Market The mRNA synthesis and manufacturing market is on a promising trajectory, with projections indicating substantial growth from USD 624.4 million to USD 738.3 million by 2029. This expansion translates into a compound annual growth rate (CAGR) of 3.4%. Several factors are propelling this growth, including an...

Continue Reading